243 related articles for article (PubMed ID: 18700057)
1. Iptakalim protects against MPP+-induced degeneration of dopaminergic neurons in association with astrocyte activation.
Yang YJ; Zhang S; Ding JH; Zhou F; Hu G
Int J Neuropsychopharmacol; 2009 Apr; 12(3):317-27. PubMed ID: 18700057
[TBL] [Abstract][Full Text] [Related]
2. Iptakalim alleviates rotenone-induced degeneration of dopaminergic neurons through inhibiting microglia-mediated neuroinflammation.
Zhou F; Wu JY; Sun XL; Yao HH; Ding JH; Hu G
Neuropsychopharmacology; 2007 Dec; 32(12):2570-80. PubMed ID: 17356569
[TBL] [Abstract][Full Text] [Related]
3. Iptakalim ameliorates MPP+-induced astrocyte mitochondrial dysfunction by increasing mitochondrial complex activity besides opening mitoK(ATP) channels.
Zhang S; Ding JH; Zhou F; Wang ZY; Zhou XQ; Hu G
J Neurosci Res; 2009 Apr; 87(5):1230-9. PubMed ID: 19006086
[TBL] [Abstract][Full Text] [Related]
4. Activation of mitochondrial ATP-sensitive potassium channels improves rotenone-related motor and neurochemical alterations in rats.
Yang Y; Liu X; Long Y; Wang F; Ding JH; Liu SY; Sun YH; Yao HH; Wang H; Wu J; Hu G
Int J Neuropsychopharmacol; 2006 Feb; 9(1):51-61. PubMed ID: 15927086
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease by blocking microglial activation.
Moon M; Kim HG; Hwang L; Seo JH; Kim S; Hwang S; Kim S; Lee D; Chung H; Oh MS; Lee KT; Park S
Neurotox Res; 2009 May; 15(4):332-47. PubMed ID: 19384567
[TBL] [Abstract][Full Text] [Related]
6. KATP channel openers facilitate glutamate uptake by GluTs in rat primary cultured astrocytes.
Sun XL; Zeng XN; Zhou F; Dai CP; Ding JH; Hu G
Neuropsychopharmacology; 2008 May; 33(6):1336-42. PubMed ID: 17609675
[TBL] [Abstract][Full Text] [Related]
7. Systematic administration of iptakalim, an ATP-sensitive potassium channel opener, prevents rotenone-induced motor and neurochemical alterations in rats.
Yang Y; Liu X; Long Y; Wang F; Ding JH; Liu SY; Sun YH; Yao HH; Wang H; Wu J; Hu G
J Neurosci Res; 2005 May; 80(3):442-9. PubMed ID: 15795934
[TBL] [Abstract][Full Text] [Related]
8. ATP-sensitive potassium channel opener iptakalim protected against the cytotoxicity of MPP+ on SH-SY5Y cells by decreasing extracellular glutamate level.
Hu LF; Wang S; Shi XR; Yao HH; Sun YH; Ding JH; Liu SY; Hu G
J Neurochem; 2005 Sep; 94(6):1570-9. PubMed ID: 16000145
[TBL] [Abstract][Full Text] [Related]
9. Harpagoside attenuates MPTP/MPP⁺ induced dopaminergic neurodegeneration and movement disorder via elevating glial cell line-derived neurotrophic factor.
Sun X; Xiong Z; Zhang Y; Meng Y; Xu G; Xia Z; Li J; Zhang R; Ke Z; Xia Z; Hu Y
J Neurochem; 2012 Mar; 120(6):1072-83. PubMed ID: 22192054
[TBL] [Abstract][Full Text] [Related]
10. α7 nicotinic acetylcholine receptor-mediated neuroprotection against dopaminergic neuron loss in an MPTP mouse model via inhibition of astrocyte activation.
Liu Y; Hu J; Wu J; Zhu C; Hui Y; Han Y; Huang Z; Ellsworth K; Fan W
J Neuroinflammation; 2012 May; 9():98. PubMed ID: 22624500
[TBL] [Abstract][Full Text] [Related]
11. ATP-sensitive potassium channel opener iptakalim protects against MPP-induced astrocytic apoptosis via mitochondria and mitogen-activated protein kinase signal pathways.
Zhang S; Zhou F; Ding JH; Zhou XQ; Sun XL; Hu G
J Neurochem; 2007 Oct; 103(2):569-79. PubMed ID: 17635669
[TBL] [Abstract][Full Text] [Related]
12. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
Lee EY; Lee JE; Park JH; Shin IC; Koh HC
Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585
[TBL] [Abstract][Full Text] [Related]
13. Secalonic acid A protects dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP⁺)-induced cell death via the mitochondrial apoptotic pathway.
Zhai A; Zhu X; Wang X; Chen R; Wang H
Eur J Pharmacol; 2013 Aug; 713(1-3):58-67. PubMed ID: 23665112
[TBL] [Abstract][Full Text] [Related]
14. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
Saporito MS; Brown EM; Miller MS; Carswell S
J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541
[TBL] [Abstract][Full Text] [Related]
15. Modulation of 1-methyl-4-phenylpyridinium-induced mitochondrial dysfunction and cell death in PC12 cells by K(ATP) channel block.
Lee CS; Kim YJ; Ko HH; Han ES
J Neural Transm (Vienna); 2007 Mar; 114(3):297-305. PubMed ID: 17109075
[TBL] [Abstract][Full Text] [Related]
16. The mitochondrial ATP-sensitive potassium channel blocker 5-hydroxydecanoate inhibits toxicity of 6-hydroxydopamine on dopaminergic neurons.
Rodriguez-Pallares J; Parga JA; Joglar B; Guerra MJ; Labandeira-Garcia JL
Neurotox Res; 2009 Jan; 15(1):82-95. PubMed ID: 19384591
[TBL] [Abstract][Full Text] [Related]
17. Selective activation of p38 mitogen-activated protein kinase in dopaminergic neurons of substantia nigra leads to nuclear translocation of p53 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.
Karunakaran S; Saeed U; Mishra M; Valli RK; Joshi SD; Meka DP; Seth P; Ravindranath V
J Neurosci; 2008 Nov; 28(47):12500-9. PubMed ID: 19020042
[TBL] [Abstract][Full Text] [Related]
18. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease.
Du Y; Ma Z; Lin S; Dodel RC; Gao F; Bales KR; Triarhou LC; Chernet E; Perry KW; Nelson DL; Luecke S; Phebus LA; Bymaster FP; Paul SM
Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14669-74. PubMed ID: 11724929
[TBL] [Abstract][Full Text] [Related]
19. Fucoidan protects against dopaminergic neuron death in vivo and in vitro.
Luo D; Zhang Q; Wang H; Cui Y; Sun Z; Yang J; Zheng Y; Jia J; Yu F; Wang X; Wang X
Eur J Pharmacol; 2009 Sep; 617(1-3):33-40. PubMed ID: 19545563
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor 9 prevents MPP+-induced death of dopaminergic neurons and is involved in melatonin neuroprotection in vivo and in vitro.
Huang JY; Hong YT; Chuang JI
J Neurochem; 2009 Jun; 109(5):1400-12. PubMed ID: 19476551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
